11-1584631-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001005922.1(KRTAP5-1):c.619G>A(p.Gly207Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000411 in 1,459,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001005922.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP5-1 | NM_001005922.1 | c.619G>A | p.Gly207Ser | missense_variant | 1/1 | ENST00000382171.2 | NP_001005922.1 | |
KRTAP5-AS1 | NR_021489.2 | n.328+11563C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP5-1 | ENST00000382171.2 | c.619G>A | p.Gly207Ser | missense_variant | 1/1 | NM_001005922.1 | ENSP00000371606 | P1 | ||
KRTAP5-AS1 | ENST00000424148.1 | n.328+11563C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 8AN: 143642Hom.: 0 Cov.: 31 FAILED QC
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251076Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135712
GnomAD4 exome AF: 0.0000411 AC: 60AN: 1459698Hom.: 0 Cov.: 31 AF XY: 0.0000372 AC XY: 27AN XY: 726220
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000557 AC: 8AN: 143750Hom.: 0 Cov.: 31 AF XY: 0.0000717 AC XY: 5AN XY: 69712
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at